🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with tirzepatide dual agonism: gip + glp-1 synergistic mechanism? Page 4

Has anyone dealt with tirzepatide dual agonism: gip + glp-1 synergistic mechanism?

robert_kc Fri, Apr 5, 2024 at 12:28 AM 49 replies 2,765 viewsPage 4 of 10
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Apr 5, 2024 at 6:08 AM#16

Just wanted to say — for anyone reading this Has anyone dealt thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Apr 5, 2024 at 10:08 AM
6 17MariaRD, AussieAnna, BethLabQueen and 3 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Apr 5, 2024 at 6:25 AM#17

robert_kc's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 66 lbs in 11 months.

One thing I would add that robert_kc did not mention: the mental health improvements were just as significant.

21 21DoseLogDan, SleepFixSam, PurityPaulOR and 18 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Apr 5, 2024 at 6:42 AM#18

Saving this for reference. Top-tier content.

Last edited: Apr 5, 2024 at 7:42 AM
43 21oliver_london, tane_welly, Dr.PathRoch and 40 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Apr 5, 2024 at 6:59 AM#19

As a pharmacist, I want to add some clinical context to this discussion on Has anyone dealt with tirzepatide dual.

Building on what robert_kc said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
44 5Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 41 others
Reply Quote Save Share Report
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Apr 5, 2024 at 7:16 AM#20

Subscribing to this thread. Has anyone dealt with is exactly what I've been researching. 🙏

Last edited: Apr 5, 2024 at 8:16 AM
9 9mike_mealprep, NicoleRaleigh, james_edin and 6 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register